KLRB1 and juvenile idiopathic arthritis: It is therefore likely that the therapeutically approaches were the IL-1β activity is blocked, like in JIA patients, are effective because acting on these Th1 CD161+ IL-1RI cells whose number correlate with some parameter disease.